The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
However, some research shows that planned, short breaks from calorie restriction, not breaks from healthy eating, helped people lose more weight overall and maintain more of it long term
How can clinicians improve long-term tolerability of GLP-1 medications
Side effects include medullary thyroid cancer, kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis